None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients with ERM or macular hole requiring ILM peeling - Ability to be able to meet follow-up requirements - A person who voluntarily decides to participate in clinical trial and signs a consent form
Exclusion criteria
Exclusion criteria: - A history of previous vitrectomy - Patients with any other retinal or choroidal diseases including diabetic retinopathy, retinal vein occlusion, retinal detachment, uveitis, and age-related macular degeneration - A history of ocular trauma including corneoscleral laceration - Corneal diseases including corneal opacity or corneal dystrophy - Follow-up period less than 3 months during clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the mean color contrast ratio of groups receiving different concentrations (range: 0.075% to 0.0125%) of ICG dye. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of muscle tone and stiffness;Best-corrected visual acuity (BCVA);operating time | — |
Countries
Korea, Republic of
Contacts
Kyungpook National University Hospital